Lecture 6 (Coronary Bloodflow and Angina) Flashcards

1
Q

What two molecules are key to promoting vasodilation?

A
  • Cyclic GMP and protein kinase G (PKG).
  • Anytime cGMP or PKG is unregulated in a VSM cell, the VSM will relax.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Low epinephrine levels cause:

High epinephrine levels cause:

A
  • low epinephrine: vasodilation via β2
  • high epinephrine: vasoconstriction via α1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Steps in low epinephrine levels causing vasodilation:

A
  1. low epinephrine levels
  2. β2 adrenoreceptors
  3. epithelial nitric oxide synthase (eNOS)
  4. NO
  5. guanalyl cyclase
  6. cGMP
  7. PKG
    • PKG inactivates calcium channels, preventing contraction and vasoconstriction, and activates SERCA channels, calcium flows out and VSM relaxes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does protein kinase G (PKG) cause vasodilation?

A
  1. prevention of calcium inflow via Type-L calcium channel isoform inactivation.
  2. promotion of calcium outflow via SERCA channel activation.
  • decreased sarcoplasmic calcium levels causes VSM relaxation and vasodilation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Vasodilatory factors (7):

A
  1. CO2
  2. NO
  3. H+ (protons)
  4. lactic acid (protons)
  5. adenosine
  6. thrombin
  7. histamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Steps in vasodilatory factors (CO2, protons, etc.) causing vasodilation:

A
  1. bind to specific receptors
  2. epithelial nitric oxide synthase (eNOS)
  3. Nitric oxide
  4. guanalyl cyclase
  5. cGMP
  6. PKG
    • PKG inactivates calcium channels, preventing contraction and vasoconstriction, and activates SERCA channels, calcium flows out and VSM relaxes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Steps in vasoconstriction:

A
  1. epi/norepi
  2. α1 adrenoreceptors VSM
  3. Gq proteins
  4. PLC
  5. PKC
    • PKC activates calcium channels causing calcium influx and inactivates SERCA channels via arachadonic acid/PGF2α
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Primary protein involved in vasodilation and primary protein involved in vasoconstriction:

A
  • vasodilation: PKG
  • vasoconstriction: PKC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How are SERCA channels inactivated during vasoconstriction:

A
  • PKC and arachadonic acid activate PGF2α
  • PGF2α inactivates SERCA channels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What causes vasoconstriction at low levels of SNS tone, and what causes vasoconstriction at moderate to high levels of SNS tone?

A
  • low SNS tone: norepi
  • mod-high SNS tone: norepi, epi, ATP, NPY
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The vascular network is comprised of three functional components:

A
  • resistance (arteries and arterioles)
  • exchange (capillaries)
  • capacitance (veins)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Right atrial response to low pressure (low RAP) and high pressure (high RAP):

A
  • Low pressure: low pressure baroreceptor activated; SNS tone increased.
  • High pressure: ANP released in response to volume overload. Vasodilation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

As RAP (venous return) increases, what must also increase?

A
  • cardiac output.
  • necessary in order to maintain proper pressures.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Steps in how a sick left heart leads to an increase in RAP:

A
  1. reduced EF = increased LVP.
  2. back pressure from LV to LA.
  3. back pressure from LA to pulmonary veins.
  4. Pulmonary BP increases; increased afterload on RV.
  5. increased RVP.
  6. back pressure on RAP; RAP rises.
  7. venous return decreases; LV works harder to maintain CO.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does increased RAP lead to?

A
  1. reduction in venous return; increased venous pressure.
  2. possibly hepatic-portal hypertension (IVC).
  3. possibly jugular vein distention (SVC).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When does maximal and minimal coronary blood flow/oxygen uptake occur?

A
  • maximal: diastole
  • minimal: systole
17
Q

What occurs to coronary VSM in the presence of reduced flow/oxygen levels?

A
  1. oxidative phosphorylation and generation of ATP impaired.
  2. formation of ADP, AMP, and ultimately adenosine.
  3. adenosine blocks Ca2+ entry into VSM.
  4. vasodilation.
18
Q

Adrenoreceptors mediating coronary VSM contraction (vasoconstriction):

A
  • α1 and α2 adrenoreceptors
  • MOSTLY α2 adrenoreceptors
19
Q

Effect of SNS tone on coronary VSM in healthy and non-healthy hearts:

A
  • healthy: SNS binding to α2 adrenoreceptors does not cause vasoconstriction. Vasodilation occurs due local vasodilatory metabolites (CO2 and protons) produced via myocardium work.
  • non-healthy: local vasodilatory metabolites not produced at sufficient levels. SNS tone causes vasoconstriction of coronary VSM and ischemia.
20
Q

During physiologic conditions, how do the coronary arteries maintain a state of relative vasodilation?

A
  • local production of vasodilators by (healthy) vascular endothelium during contraction.
  • if impaired, SNS causes vasoconstriction, which leads to ischemia.
21
Q

The major determinants of myocardial O2 requirements in order of demand:

A
  1. ventricular wall stress (i.e. systolic ventricular pressure)
  2. HR
  3. contractility (inotropic state)
22
Q

Ischemia is:

A
  • a localized anemia due to a reduction in blood supply.
23
Q

Ischemic heart disease results from:

A
  • an imbalance between O2 supply and myocardial demand
24
Q

Cause of dyspnea due to cardiac ischemia:

A
  1. impediment in coronary blood flow.
  2. localized anemia.
  3. decreased oxygen levels.
  4. impaired LV function.
  5. increased LVP; increased LAP; increased pulmonary BP.
  6. dyspnea.
25
Q

Two general mechanisms underlie the pathophysiology of cardiac ischemia/angina:

A
  1. fixed vessel narrowing (e.g. atherosclerotic plaques)
  2. abnormal vascular tone (e.g. VSM dysfunction)
26
Q

Angina pecotoris is:

A
  • chest pain/discomfort due to cardiac ischemia to one or more part of the ventricular myocardium.
  • resolves upon rest.
27
Q

ECG manifestation of chronic stable angina:

A
  1. inverted or flattened T waves
  2. ST depression
28
Q

What does the ECG show?

A

ST depression

possible angina/cardiac ischemia

29
Q

Steps in the cause of ischemic chest pain:

A
  1. hypoxia due to ischemia.
  2. hypoxia decreases ATP production and increases lactic acid.
  3. decreased ATP compromises Na+/K+ ATPase and increases adenosine.
  4. increased lactic acid causes local acidosis.
  5. sarcolemma integrity compromised and myocardial injury occurs.
  6. adenosine and injured myocardium compounds bind to nociceptors.
30
Q

Hypoxia due to ischemia ultimately causes what three symptoms related to angina?

A
  1. tachycardia (SNS activation)
  2. diaphoresis (SNS activation)
  3. dyspnea (decreased LV function leads to pulmonary BP increase)
31
Q

Medications for angina based on angina physiology (4):

A
  • angina is due to cardiac ischemia:
    1. vasodilator (NO)
    2. beta-blocker (negative inotrope; decrease oxygen demand)
    3. calcium channel blockers (vasodilate and decrease HR)
    4. ranolazine (impairs prolonged late Na+ current)
32
Q

The two sodium currents of cardiac myocyte depolarization (plateau potentials):

A
  1. early current
  2. late current (INAL)
33
Q

What sodium current is prolonged in cardiac myocyte depolarization in ischemic myocardium?

A
  • late current (INAL)
34
Q

How does a prolonged late current (INAL) excaberate angina/cardiac ischemia?

A
  1. more Na+ enters myocytes.
  2. NCX function impaired, more Ca2+ in myocytes.
  3. increased Ca2+ levels impairs LV relaxation.
  4. LV wall tension increases.
  5. LV oxygen demand increases.
35
Q

What drug blocks a prolonged late current (INAL) during cardiac myocyte depolarization?

A

ranolazine